Federal regulators are turning up the heat on sellers of copycat weight-loss drugs. Earlier this summer, the Food and Drug Administration sent warning letters to dozens of companies marketing compounded GLP-1s over misleading advertising.
That action is more than welcome. The growing trade in compounded GLP-1s continues to expose patients to serious health risks. If left unchecked, it could have devastating effects on the future of medical innovation.
As the shutdown of the federal government extends beyond 30 days, the key…
The Colorado Supreme Court, in a break with its long hostility to TABOR, finally…
The following testimony was submitted by the Grassroot Institute of Hawaii for…
Labor market Albert Lea Tribune: Minnesota jobs stable over the month and grew…
A warning This summer I blew the whistle on the Minnesota Department of…
FOR IMMEDIATE RELEASEOctober 28, 2025 Mississippi Center for Public Policy…
Chicago aldermen for the first time pushed through their own budget,…
The following commentary is based on remarks presented by Ted Kefalas of the…
The Star Tribune reported this weekend about several data center projects that…
Policy analyst, Harris Van Pate, joined the WGAN Morning News to discuss Maine…
Welcome, Login to your account.
Welcome, Create your new account
A password will be e-mailed to you.
